Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

4-chloro-m-cresol is a trigger of malignant hyperthermia in susceptible swine.

Wappler F, Scholz J, Fiege M, Kolodzie K, Kudlik C, Weisshorn R, Schulte am Esch J.

Anesthesiology. 1999 Jun;90(6):1733-40.

PMID:
10360873
2.

[4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].

Wappler F, Scholz J, von Richthofen V, Fiege M, Steinfath M, Schulte am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1997 Sep;32(9):541-8. German.

PMID:
9417254
3.

4-chloro-m-cresol triggers malignant hyperthermia in susceptible swine at doses greatly exceeding those found in drug preparations.

Iaizzo PA, Johnson BA, Nagao K, Gallagher WJ.

Anesthesiology. 1999 Jun;90(6):1723-32.

PMID:
10360872
4.

In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine.

Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Kolodzie K, Schulte Am Esch J.

Anesthesiology. 2003 Apr;98(4):944-9.

PMID:
12657857
5.

[Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].

Gerbershagen MU, Wappler F, Fiege M, Weisshorn R, Kolodzie K, Schulte am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Feb;39(2):81-6. German.

PMID:
14767797
6.

The impact of 4-chloro-m-cresol in heparin formulas on malignant hyperthermia: in vitro and in vivo.

Anetseder M, Ritter L, Horbaschek H, Hartung E, Roewer N.

Acta Anaesthesiol Scand. 2000 Mar;44(3):338-42.

PMID:
10714851
7.

Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.

Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Kolodzie K, Schulte am Esch J.

Eur J Anaesthesiol. 2005 Apr;22(4):283-8.

PMID:
15892406
8.

[Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].

Gerbershagen MU, Fiege M, Weisshorn R, Kolodzie K, Wappler F.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Mar;39(3):147-52. German.

PMID:
15042504
9.

Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.

Gilly H, Musat I, Fricker R, Bittner RE, Steinbereithner K, Kress HG.

Anesth Analg. 1997 Jul;85(1):149-54.

PMID:
9212139
10.

[Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].

Fiege M, Wappler F, Scholz J, von Richthofen V, Brinken B, Schulte am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Sep;33(9):557-63. German.

PMID:
9787864
11.

4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.

Ording H, Glahn K, Gardi T, Fagerlund T, Bendixen D.

Acta Anaesthesiol Scand. 1997 Sep;41(8):967-72.

PMID:
9311392
12.

Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").

Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J.

Anesthesiology. 2003 Nov;99(5):1132-6.

PMID:
14576550
13.
14.

In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swine.

Gerbershagen MU, Wappler F, Fiege M, Weilsshorn R, Alberts PA, von Breunig F, Schulte am Esch J.

Eur J Anaesthesiol. 2002 Feb;19(2):135-40.

PMID:
11999597
16.

Effects of theophylline on anesthetized malignant hyperthermia-susceptible pigs.

Fiege M, Weisshorn R, Kolodzie K, Wappler F, Gerbershagen MU.

J Biomed Biotechnol. 2011;2011:937479. doi: 10.1155/2011/937479.

17.

Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.

Wappler F, Anetseder M, Baur CP, Censier K, Doetsch S, Felleiter P, Fiege M, Fricker R, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Hopkins PM, Klingler W, Lehmann-Horn F, Nivoche Y, Tegazzin V, Tzanova I, Urwyler A, Weisshorn R, Schulte am Esch J.

Eur J Anaesthesiol. 2003 Jul;20(7):528-36.

PMID:
12884985
18.

Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.

Fiege M, Wappler F, Scholz J, Weisshorn R, von Richthofen V, Schulte am Esch J.

J Clin Anesth. 2000 Mar;12(2):123-8.

PMID:
10818326
19.

Magnesium does not influence the clinical course of succinylcholine-induced malignant hyperthermia.

Metterlein T, Schuster F, Kranke P, Hager M, Roewer N, Anetseder M.

Anesth Analg. 2011 May;112(5):1174-8. doi: 10.1213/ANE.0b013e31821263d6.

PMID:
21474662
20.

Supplemental Content

Support Center